|
1
|
Deng Y, Li H, Wang M, Li N, Tian T, Wu Y,
Xu P, Yang S, Zhai Z, Zhou L, et al: Global burden of thyroid
cancer from 1990 to 2017. JAMA Netw Open. 3:e2087592020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao J, Zhang M, Zhang L, Lou J, Zhou F and
Fang M: Non-coding RNA in thyroid cancer-Functions and mechanisms.
Cancer Lett. 496:117–126. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Javed Z, Ahmed Shah F, Rajabi S, Raza Q,
Iqbal Z, Ullah M, Ahmad T, Salehi B, Sharifi-Rad M, Pezzani R, et
al: LncRNAs as potential therapeutic targets in thyroid cancer.
Asian Pac J Cancer Prev. 21:281–287. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peng X, Zhang K, Ma L, Xu J and Chang W:
The Role of long non-coding RNAs in thyroid cancer. Front Oncol.
10:9412020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liyanarachchi S, Gudmundsson J,
Ferkingstad E, He H, Jonasson JG, Tragante V, Asselbergs FW, Xu L,
Kiemeney LA, Netea-Maier RT, et al: Assessing thyroid cancer risk
using polygenic risk scores. Proc Natl Acad Sci USA. 117:5997–6002.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Y, Jin T, Shen H, Yan J, Guan M and
Jin X: Identification of long non-coding RNA expression profiles
and Co-expression genes in thyroid carcinoma based on the cancer
genome atlas (TCGA) database. Med Sci Monit. 25:9752–9769. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ghafouri-Fard S, Mohammad-Rahimi H and
Taheri M: The role of long non-coding RNAs in the pathogenesis of
thyroid cancer. Exp Mol Pathol. 112:1043322020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mahmoudian-Sani MR, Jalali A, Jamshidi M,
Moridi H, Alghasi A, Shojaeian A and Mobini GR: Long non-coding
RNAs in thyroid cancer: Implications for pathogenesis, diagnosis,
and therapy. Oncol Res Treat. 42:136–142. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang X, Zhang H, Yang Q and Pang L:
LncRNA SOX2OT affects cervical cancer cell growth, migration and
invasion by regulating SOX2. Cell Cycle. 19:1391–1403. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Wu N, Luo X, Zhang X, Liao Q and
Wang J: SOX2OT, a novel tumor-related long non-coding RNA. Biomed
Pharmacother. 123:1097252020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li PY, Wang P, Gao SG and Dong DY: Long
Noncoding RNA SOX2-OT: Regulations, functions, and roles on mental
Illnesses, cancers, and diabetic complications. Biomed Res Int.
2020:29015892020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhan Y, Chen Z, He S, Gong Y, He A, Li Y,
Zhang L, Zhang X, Fang D, Li X and Zhou L: Long non-coding RNA
SOX2OT promotes the stemness phenotype of bladder cancer cells by
modulating SOX2. Mol Cancer. 19:252020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei CX, Wong H, Xu F, Liu Z, Ran L and
Jiang RD: IRF4-induced upregulation of lncRNA SOX2-OT promotes cell
proliferation and metastasis in cholangiocarcinoma by regulating
SOX2 and PI3K/AKT signaling. Eur Rev Med Pharmacol Sci.
22:8169–8178. 2018.PubMed/NCBI
|
|
14
|
Li Z, Jiang P, Li J, Peng M, Zhao X, Zhang
X, Chen K, Zhang Y, Liu H, Gan L, et al: Tumor-derived exosomal
lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in
pancreatic ductal adenocarcinoma. Oncogene. 37:3822–3838. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kretz M, Webster DE, Flockhart RJ, Lee CS,
Zehnder A, Lopez-Pajares V, Qu K, Zheng GX, Chow J, Kim GE, et al:
Suppression of progenitor differentiation requires the long
noncoding RNA ANCR. Genes Dev. 26:338–343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pan L, Xiao X, Zhao Y, Yin L, Fu M, Zhang
X and Jiang P: The functional roles of long noncoding RNA DANCR in
Human Cancers. J Cancer. 11:6970–6981. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hao YP, Qiu JH, Zhang DB and Yu CG: Long
non-coding RNA DANCR, a prognostic indicator, promotes cell growth
and tumorigenicity in gastric cancer. Tumour Biol. Jun
15–2017.(Epub ahead of print). doi: 10.1177/1010428317699798.
View Article : Google Scholar
|
|
18
|
Ma X, Wang X, Yang C, Wang Z, Han B, Wu L
and Zhuang L: DANCR Acts as a diagnostic biomarker and promotes
tumor growth and metastasis in hepatocellular carcinoma. Anticancer
Res. 36:6389–6398. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Y, Zhang M, Liang L, Li J and Chen YX:
Over-expression of lncRNA DANCR is associated with advanced tumor
progression and poor prognosis in patients with colorectal cancer.
Int J Clin Exp Pathol. 8:114802015.PubMed/NCBI
|
|
20
|
Tao W, Wang C, Zhu B, Zhang G and Pang D:
LncRNA DANCR contributes to tumor progression via targetting
miR-216a-5p in breast cancer: LncRNA DANCR contributes to tumor
progression. Biosci Rep. 39:BSR201816182019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan Y, Shi Q, Yuan X, Xue C, Shen S and He
Y: DANCR: An emerging therapeutic target for cancer. Am J Transl
Res. 12:4031–4042. 2020.PubMed/NCBI
|
|
22
|
Li Z, Hou P, Fan D, Dong M, Ma M, Li H,
Yao R, Li Y, Wang G, Geng P, et al: The degradation of EZH2
mediated by lncRNA ANCR attenuated the invasion and metastasis of
breast cancer. Cell Death Differ. 24:59–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang K, Lv J, Peng X, Liu J, Li C, Li J,
Yin N, Li H and Li Z: Down-regulation of DANCR acts as a potential
biomarker for papillary thyroid cancer diagnosis. Biosci Rep. Apr
23–2019.(Epub ahead of print). doi: 10.1042/BSR20181618.
|
|
24
|
Ghafouri-Fard S, Dashti S, Taheri M and
Omrani MD: TINCR: An lncRNA with dual functions in the
carcinogenesis process. Non-coding RNA Res. 5:109–115. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sharma U, Barwal TS, Malhotra A, Pant N,
Vive K, Dey D, Gautam A, Tuli HS, Vasquez KM and Jain A: Long
non-coding RNA TINCR as potential biomarker and therapeutic target
for cancer. Life Sci. 257:1180352020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
You X, Zhao Y, Sui J, Shi X, Sun Y, Xu J,
Liang G, Xu Q and Yao Y: Integrated analysis of long noncoding RNA
interactions reveals the potential role in progression of human
papillary thyroid cancer. Cancer Med. 7:5394–5410. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fu XM, Guo W, Li N, Liu HZ, Liu J, Qiu SQ,
Zhang Q, Wang LC, Li F and Li CL: The expression and function of
long noncoding RNA lncRNA-ATB in papillary thyroid cancer. Eur Rev
Med Pharmacol Sci. 21:3239–3246. 2017.PubMed/NCBI
|
|
29
|
Han CG, Huang Y and Qin L: Long Non-Coding
RNA ZFAS1 as a novel potential biomarker for predicting the
prognosis of thyroid cancer. Med Sci Monit. 25:2984–2992. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bolha L, Ravnik-Glavač M and Glavač D:
Long noncoding RNAs as biomarkers in cancer. Dis Markers.
2017:72439682017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Amaral PP, Neyt C, Wilkins SJ,
Askarian-Amiri ME, Sunkin SM, Perkins AC and Mattick JS: Complex
architecture and regulated expression of the Sox2ot locus during
vertebrate development. RNA. 15:2013–2027. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang E and Li X: LncRNA SOX2-OT regulates
proliferation and metastasis of nasopharyngeal carcinoma cells
through miR-146b-5p/HNRNPA2B1 pathway. J Cell Biochem.
120:16575–16588. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Santiago K, Chen Wongworawat Y and Khan S:
Differential MicroRNA-signatures in thyroid cancer subtypes. J
Oncol. 2020:20523962020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu N, Tian Y, Song Y and Zang L:
miR-122-5p suppresses the oncogenesis of PTC by inhibiting DUSP4
expression. Mol Med Rep. 23:3682021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen X, Li M, Zhou H and Zhang L: miR-132
Targets FOXA1 and exerts tumor-suppressing functions in thyroid
cancer. Oncol Res. 27:4312019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xue L, Yan H, Chen Y, Zhang Q, Xie X, Ding
X, Wang X, Qian Z, Xiao F, Song Z, et al: EZH2 upregulation by ERα
induces proliferation and migration of papillary thyroid carcinoma.
BMC Cancer. 19:10942019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Teng Y, Kang H and Chu Y: Identification
of an exosomal long noncoding RNA SOX2-OT in plasma as a promising
biomarker for lung squamous cell carcinoma. Genet Test Mol
Biomarkers. 23:235–240. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shi XM and Teng F: Up-regulation of long
non-coding RNA Sox2ot promotes hepatocellular carcinoma cell
metastasis and correlates with poor prognosis. Int J Clin Exp
Pathol. 8:4008–4014. 2015.PubMed/NCBI
|
|
40
|
Wang S and Jiang M: The long non-coding
RNA-DANCR exerts oncogenic functions in non-small cell lung cancer
via miR-758-3p. Biomed Pharmacother. 103:94–100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pan Z, Wu C, Li Y, Li H, An Y, Wang G, Dai
J and Wang Q: LncRNA DANCR silence inhibits SOX5-medicated
progression and autophagy in osteosarcoma via regulating
miR-216a-5p. Biomed Pharmacother. 122:1097072020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Q, Jiang Y, Zhong G, Lu Y, Song T,
Zhang Y, Wu J, Zhang M, Liang X, Zhou L, et al: Long noncoding RNA
DANCR regulates cell proliferation by stabilizing SOX2 mRNA in
nasopharyngeal carcinoma. Am J Pathol. 190:2343–2354. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li J and Zhou L: Overexpression of lncRNA
DANCR positively affects progression of glioma via activating
Wnt/β-catenin signaling. Biomed Pharmacother. 102:602–607. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hitu L, Gabora K, Bonci EA, Piciu A, Hitu
AC, Ștefan PA and Piciu D: MicroRNA in papillary thyroid carcinoma:
A systematic review from 2018 to June 2020. Cancers (Basel).
12:31182020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lu HW and Liu XD: UCA1 promotes papillary
thyroid carcinoma development by stimulating cell proliferation via
Wnt pathway. Eur Rev Med Pharmacol Sci. 22:5576–5582.
2018.PubMed/NCBI
|
|
46
|
Pan L, Liang W, Gu J, Zang X, Huang Z, Shi
H, Chen J, Fu M, Zhang P, Xiao X, et al: Long noncoding RNA DANCR
is activated by SALL4 and promotes the proliferation and invasion
of gastric cancer cells. Oncotarget. 9:1915–1930. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Vouri M and Hafizi S: TAM Receptor
tyrosine kinases in cancer drug resistance. Cancer Res.
77:2775–2778. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Collina F, La Sala L, Liotti F, Prevete N,
La Mantia E, Chiofalo MG, Aquino G, Arenare L, Cantile M, Liguori
G, et al: AXL Is a novel predictive factor and therapeutic target
for radioactive iodine refractory thyroid cancer. Cancers (Basel).
11:7852019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu XF, Hao JL, Xie T, Pant OP, Lu CB, Lu
CW and Zhou DD: The BRAF activated non-coding RNA: A pivotal long
non-coding RNA in human malignancies. Cell Prolif. 51:e124492018.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pahlevan Kakhki M, Rakhshi N, Emami
Aleagha MS, Abdari M, Alikhah A, Safarian G, Behmanesh M and
Nikravesh A: Differential expression of STAT3 gene and its
regulatory long non-coding RNAs, namely lnc-DC and THRIL, in two
eastern Iranian ethnicities with multiple sclerosis. Neurol Sci.
41:561–568. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen F, Qi S, Zhang X, Wu J, Yang X and
Wang R: lncRNA PLAC2 activated by H3K27 acetylation promotes cell
proliferation and invasion via the activation of Wnt/β-catenin
pathway in oral squamous cell carcinoma. Int J Oncol. 54:1183–1194.
2019.PubMed/NCBI
|
|
52
|
Chen Z, Liu H, Yang H, Gao Y, Zhang G and
Hu J: The long noncoding RNA, TINCR, functions as a competing
endogenous RNA to regulate PDK1 expression by sponging miR-375 in
gastric cancer. Onco Targets Ther. 10:3353–3362. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tian F, Xu J, Xue F, Guan E and Xu X:
TINCR expression is associated with unfavorable prognosis in
patients with hepatocellular carcinoma. Biosci Rep.
37:BSR201703012017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhu ZJ and He JK: TINCR facilitates
non-small cell lung cancer progression through BRAF-activated MAPK
pathway. Biochem Biophys Res Commun. 497:971–977. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kretz M, Siprashvili Z, Chu C, Webster DE,
Zehnder A, Qu K, Lee CS, Flockhart RJ, Groff AF, Chow J, et al:
Control of somatic tissue differentiation by the long non-coding
RNA TINCR. Nature. 493:231–235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Song L, Qi Y and Lin M: Long noncoding RNA
PLAC2 regulates PTEN in retinoblastoma and participates in the
regulation of cancer cell apoptosis. Oncol Lett. 19:2489–2494.
2020.PubMed/NCBI
|
|
57
|
Xia H, Xiu M, Gao J and Jing H: LncRNA
PLAC 2 downregulated miR-21 in non-small cell lung cancer and
predicted survival. BMC Pulm Med. 19:1722019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Xu Y, Qiu M, Chen Y, Wang J, Xia W, Mao Q,
Yang L, Li M, Jiang F, Xu L and Yin R: Long noncoding RNA, tissue
differentiation-inducing nonprotein coding RNA is upregulated and
promotes development of esophageal squamous cell carcinoma. Dis
Esophagus. 29:950–958. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang ZY, Lu YX, Zhang ZY, Chang YY, Zheng
L, Yuan L, Zhang F, Hu YH, Zhang WJ and Li XN: Loss of TINCR
expression promotes proliferation, metastasis through activating
EpCAM cleavage in colorectal cancer. Oncotarget. 7:22639–22649.
2016. View Article : Google Scholar : PubMed/NCBI
|
